Similar studies for GEO DataSets (Select 200005287) - GEO DataSets

Warning: The NCBI web site requires JavaScript to function. more...

Format

Summary
Summary (text)
Unique Identifier List

Sort by

Default order
Number of Samples (High to Low)
Number of Samples (Low to High)

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO DataSets

Items: 5

Select item 2000052871.

Prediction of response and survival following chemotherapy in patients with advanced bladder cancer

(Submitter supplied) BACKGROUND Cisplatin-containing chemotherapy is the standard of care for patients with locally advanced and metastatic transitional cell carcinoma of the urothelium. The response rate is around 50% and tumor derived molecular prognostic markers are needed for estimation of response and survival. METHODS Affymetrix GeneChip expression profiling was carried out using tumor material from 30 patients. more...

Organism:: Homo sapiens

Type:: Expression profiling by array

Platform:: GPL96
30 Samples

Download data: CEL

Series

Accession:: GSE5287

ID:: 200005287

Select item 2000041372.

GEP associated with drug resistance in adult AML

(Submitter supplied) Acute myeloid leukemia (AML) patients are primarily resistant to induction chemotherapy in 20-50%. Previously it has been shown that resistance to the first cycle of induction chemotherapy is an independent prognostic factor. We investigated whether resistance to chemotherapy can be represented by gene-expression profiling, and which genes are associated with resistance. cDNA microarrays containing ~41.000 features were used to compare the gene-expression profile of AML blasts between 33 patients with good or poor response to induction chemotherapy. more...

Organism:: Homo sapiens

Type:: Expression profiling by array

Platforms:: GPL3405 GPL3344
35 Samples

Download data

Series

Accession:: GSE4137

ID:: 200004137

Select item 2000112643.

A predictive and prognostic 38-gene expression signature for metastatic relapse in breast cancer

(Submitter supplied) Background Currently, no gene-expression signature (GES) established from node-positive cohorts, able to predict breast cancer evolution after systemic adjuvant chemotherapy, exists. Methods Gene-expression profiles of 252 node-positive patients (median follow-up: 7.7 years), mostly included in a randomized clinical trial (PACS01), receiving systemic adjuvant regimen, were determined by means of cDNA custom array representing 5,776 distinct genes. more...

Organism:: Homo sapiens

Type:: Expression profiling by array

Platform:: GPL4819
252 Samples

Download data: TXT

Series

Accession:: GSE11264

ID:: 200011264

PubMed Full text in PMC Similar studies Analyze with GEO2R

Select item 2000054794.

Gene expression signatures predict outcome in non-muscle invasive bladder carcinoma - a multi-center validation study

(Submitter supplied) Background Clinically useful molecular markers predicting the clinical course of patients diagnosed with non-muscle invasive bladder cancer are needed to improve treatment outcome. Methods We used custom designed oligonucleotide microarrays to validate four previously reported gene expression signatures for molecular diagnosis of disease stage and carcinoma in situ, and for predicting disease recurrence and progression. more...

Organism:: Homo sapiens

Type:: Expression profiling by array

Platform:: GPL4060
808 Samples

Download data: TXT

Series

Accession:: GSE5479

ID:: 200005479

Select item 2000018275.

Waldman Bladder tumors

(Submitter supplied) 80 bladder tumors of different stages, grades and histologies analyzed on costom made cDNA arrays with 10638 gene elements Keywords: parallel sample